Published guidance, NICE advice and quality standards | Guidance

Showing 691 to 700 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis	TA254	25 April 2012	25 April 2012
Pharmalgen for the treatment of bee and wasp venom allergy	TA246	22 February 2012	22 February 2012
Tocilizumab for the treatment of rheumatoid arthritis	TA247	22 February 2012	22 February 2012
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy	TA242	25 January 2012	25 January 2012
Rituximab for the first-line treatment of stage III-IV follicular lymphoma	TA243	25 January 2012	25 January 2012
Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults	TA245	25 January 2012	25 January 2012
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer	TA118	24 January 2007	1 January 2012
Tocilizumab for the treatment of systemic juvenile idiopathic arthritis	TA238	14 December 2011	14 December 2011
Fulvestrant for the treatment of locally advanced or metastatic breast cancer	TA239	14 December 2011	14 December 2011
Mifamurtide for the treatment of osteosarcoma	TA235	26 October 2011	26 October 2011